Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study

2021; Elsevier BV; Volume: 21; Issue: 7 Linguagem: Inglês

10.1016/s1473-3099(21)00224-3

ISSN

1474-4457

Autores

Cristina Menni, Kerstin Kläser, Anna May, Lorenzo Polidori, Joan Capdevila Pujol, Panayiotis Louca, Carole H. Sudre, Long H. Nguyen, David A. Drew, Jordi Merino, Christina Hu, Somesh Selvachandran, Michela Antonelli, Benjamin Murray, Liane S. Canas, Erika Molteni, Mark S. Graham, Marc Modat, Amit D. Joshi, Massimo Mangino, Alexander Hammers, Anna L. Goodman, Andrew T. Chan, Jonathan Wolf, Claire J. Steves, Ana M. Valdes, Sébastien Ourselin, Tim D. Spector,

Tópico(s)

Vaccine Coverage and Hesitancy

Resumo

The Pfizer-BioNTech (BNT162b2) and the Oxford-AstraZeneca (ChAdOx1 nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase 3 trials. We aimed to investigate the safety and effectiveness of these vaccines in a UK community setting.

Referência(s)